The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety

European Neuropsychopharmacology

Volumn 6, Issue 1, 1996, Pages 55-61

  Jessa, Maria ^a   Nazar, Maciej ^a   Bidzinski, Andrzej ^a   Plaznik, Adam ^a,b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Diazepam; NMDA receptor complex antagonists; Open field test; Rat; Repeated treatment; Vogel conflict test

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; DIAZEPAM; DIZOCILPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029875219     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-977X(95)00068-Z     Document Type: Article

References (31)

1. Carter, A.J. (1994) Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination. J. Pharmacol. Exp. Ther. 269, 573-580.
2. File, S.E. (1990) The history of benzodiazepine dependency: a review of animal studies. Neurosci. Biobehav. Rev. 14, 135-146.
3. Gandolfi, O., Rimondini, R. and Dall'Olio, R. (1992) The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms. Neuropharmacology, 31, 1111-1114.
4. Gandolfi, O. and Dall'Olio, R. (1993) Chronic treatment with MK-801 decreases D2 dopamine receptor function in the rat striatum. Pharmacol. Biochem. Behav. 44, 683-687.
5. Gauchy, C., Desban, M., Glowinski, J. and Kemel, M.L. (1994) NMDA regulation of dopamine release from proximal and distal dendrites in the cat substantia nigra. Brain Res. 635, 249-256.
6. Glowinski, J. and Iversen, L.L. (1966) Regional studies of catecholamines in the rat brain. J. Neurochem., 13, 655-669.
7. Hargreaves, E.L. and Cain, D.P. (1995) MK801-induced hyperactivity: duration of effects in rats. Pharmacol. Biochem. Behav. 51, 13-19.
8. Henry, D.J. and White, F.J. (1991) Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258, 882-890.
9. 3H-SCH-23390 induced by MK-801 in the mouse striatum. Neuropharmacology 32, 341-348.
10. Lannes, B., Micheletti, G., Warter, J-M., Kempf, E. and Di Scala, G. (1991) Behavioral, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat. Neurosci. Lett. 128, 177-181.
11. Lannes, B., Bernard, V., Bloch, B. and Micheletti, G. (1995) Chronic treatment with dizocilpine maleate increases the number of striatal neurons expressing the D2 receptor gene. Neuroscience 65, 431-438.
12. Maj, J., Klimek, V., Golembiowska, K., Rogoz, K. and Skuza, K. (1993a) Central effects of repeated treatment with CGP 37849, a competitive NMDA receptor antagonists with potential antidepressant activity. Pol. J. Pharmacol. 45, 455-466.
13. Maj, J., Skuza, G. and Rogoz, Z. (1993b) Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity. J. Neural Transm. 6, 53-62.
14. 3H-D-AP5, suggesting down-regulation of the conical NMDA receptors. Neuroscience 30, 87-94.
15. Mennini, T., Miari, A., Presti, M.L., Rizzi, M. and Samanin, R. (1994) Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551. Eur. J. Pharmacol. 271, 93-101.
16. O'Donovan, M.C., Buckland, P.R., Spurlock, G. and McGuffin, P. (1992) Bidirectional changes in the levels of messenger RNAs encoding gamma-aminobutyric acid-A receptor alpha-subunit after flurazepam treatment. Eur. J. Pharmacol. 226, 335-341.
17. Plaznik, A., Palejko, W., Nazar, M. and Jessa, M. (1994a) Effects of antagonists at the NMDA receptor complex in two models of anxiety. Eur. Neuropsychopharmacol. 4, 503-512.
18. Plaznik, A., Stefański, R., Palejko, W., Bidzinski, A., Kostowski, W., Jessa, M. and Nazar, M. (1994b) Antidepressant treatment and limbic serotonergic mechanisms regulating rat locomotor activity. Pharmacol. Biochem. Behav. 48, 315-325.
19. Pratt, J.A., Laurie, D-J. and McCulloch, J. (1988) The effects of FG 7142 upon local cerebral glucose utilization suggest overlap between limbic structures important in anxiety and convulsion. Brain Res. 475, 218-231.
20. Rabbani, M., Wright, E.J. and Little, H.J. (1995) Tolerance to competitive NMDA antagonists, but not cross-tolerance with barbiturates. Pharmacol. Biochem. Behav. 50, 9-15.
21. Sanger, D.J., Benavides, J., Parrault, G., Morel, E., Cohen, C, Joly, D. and Zivkovic, B. (1994) Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes. Neurosci. Biobehav. Rev. 18, 355-372.
22. Schmutz, M., Porter, Ch., Jeker, A., Klebs, K., Vassout, A., Allgeier, H., Heckendorm, R., Fagg, G.E., Olpe, H.R. and van Riezen, H. (1990) The competitive NMDA receptor antagonist CGP 37849 and CGP 39551 are potent orally-active anticonvulsants in rodents. Naunyn-Schmiedeberg's Arch. Pharmacol. 342, 61-66.
23. Stefański, R., Palejko, W., Kostowski, W. and Plaznik, A. (1992) The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety. Neuropharmacology 31, 1251-1258.
24. Wedzony, K., Golembiowska, K. and Klimek, V. (1993a) MK-801-induced symptoms of sensitization - the lack of correlation with the extracellular concentration of dopamine in the rat. Brain Res. 625, 333-336.
25. Wedzony, K., Klimek, V. and Golembiowska, K. (1993b) MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors. Brain Res. 622, 325-329.
26. Wedzony, K., Golembiowska, K. and Zazula, M. (1994) Differential effects of CGP 37949 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 555-562.
27. Wiley, J.L. and Balster, R.L. (1992a) Preclinical evaluation of N-methyl-D-aspartate antagonists for antianxiety effects: a review. In: Kamenka, J.M. and Domino, E.F. (Eds.), Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection?. NPP Books, Ann Arbor, MI, pp. 801-815.
28. Wiley, J.L., Porter, J.H., Compton, A.D. and Balster, R.L. (1992b) Antipunishment effects of acute and repeated administration of phencyclidine and NPC 12626 in rats. Life Sci. 50, 1519-1528.
29. Willets, J., Clissold, D.B., Hartman T.L., Brandsgaard, R.R., Hamilton, G.S. and Ferkany, J.W. (1993) Behavioral pharmacology of NPC 17742, a competitive NMDA antagonist. J. Pharmacol. Exp. Ther. 265, 1055-1062.
30. Wolf, M.E., White, F.J. and Hu, X.-T. (1993a) Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system. Behav. Pharmacol. 4, 429-442.
31. Wolf, M.E., White, F.J., Nassar, R., Brooderson, R.J. and Khansa, M.R. (1993b) Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264, 249-255.